Clinical and genomic predictors of brain metastases (BM) in non-small cell lung cancer (NSCLC): An AACR Project GENIE analysis.

被引:3
|
作者
Rahman, Protiva
LeNoue-Newton, Michele
Chaugai, Sandip
Holt, Marilyn
Jain, Neha M.
Maxwell, Christina
Micheel, Christine
Yang, Yuanchu J.
Ye, Cheng
Schultz, Nikolaus
Riely, Gregory J.
McCarthy, Caroline G.
Rizvi, Hira
Schrag, Deborah
Kehl, Kenneth L.
Lepisto, Eva M.
Yu, Celeste
Bedard, Philippe L.
Fabbri, Daniel
Warner, Jeremy Lyle
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Vanderbilt Univ, Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA
[4] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Princess Margaret Canc Ctr, Toronto, ON, Canada
关键词
D O I
10.1200/JCO.2021.39.15_suppl.2032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2032
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM).
    Skakodub, Anna
    Tringale, Kathryn Ries
    Walch, Henry S.
    Vasudevan, Harish
    Eichholz, Jordan
    Kelly, Daniel W.
    Moss, Nelson S.
    Yu, Kenny Kwok Hei
    Li, Bob T.
    Mueller, Boris
    Yang, Jonathan T.
    Beal, Kathryn
    Imber, Brandon S.
    Gomez, Daniel Richard
    Schultz, Nikolaus
    Pike, Luke Roy George
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Analysis of outcomes and brain metastases (BM) of molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials
    Cedres, S.
    Pardo Aranda, N.
    Martinez de Castro, A.
    Navarro Mendivil, A.
    Martinez Marti, A.
    Ortiz, C.
    Racca, F.
    Vilaro, M.
    Carbonell, L.
    Piera, A.
    de la Fuente, I.
    Felip, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) to the QUARTZ Clinical Trial at the Christie
    Helbrow, J.
    Bayman, N.
    Burt, P. A.
    Chittalia, A.
    Harris, M.
    Lander, H.
    Lee, L. W.
    Pemberton, L.
    Sheikh, H. Y.
    Malloy, L.
    Faivre-Finn, C.
    LUNG CANCER, 2011, 71 : S37 - S37
  • [4] Brain metastases (BM) development in molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials
    Cedres, S.
    Pardo, N.
    Navarro-Mendivil, A.
    Martinez, A.
    de Castro, A. Martinez
    Remon, J.
    Amair, F.
    Zeron, J.
    Vilaro, M.
    Felip, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Molecular predictors of brain metastases in patients with non-small cell lung carcinoma (NSCLC)
    Saad, A. G.
    Pinkus, G. S.
    Pinkus, J. L.
    Chirieac, L. R.
    LABORATORY INVESTIGATION, 2007, 87 : 329A - 330A
  • [6] Molecular predictors of brain metastases in patients with non-small cell lung carcinoma (NSCLC)
    Saad, A. G.
    Pinkus, G. S.
    Pinkus, J. L.
    Chirieac, L. R.
    MODERN PATHOLOGY, 2007, 20 : 329A - 330A
  • [7] Brain metastases (BM) in locally advanced non-small cell lung cancer (LAD-NSCLC) after multimodality treatment (MMT): Risk factors analysis.
    Ceresoli, G
    Passoni, P
    Reni, M
    Mandelli, D
    Malingher, A
    Carretta, A
    Chiesa, G
    Villa, E
    ANNALS OF ONCOLOGY, 2000, 11 : 122 - 122
  • [8] Brain metastases manifestaion of advanced non-small cell lung cancer (NSCLC)
    Koyi, H.
    Branden, E.
    Daham, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [9] SURVIVAL OF PATIENTS WITH BRAIN METASTASES AND NON-SMALL CELL LUNG CANCER (NSCLC)
    Randhawa, J. K.
    Patel, S. P.
    Stokes, T. C.
    THORAX, 2009, 64 : A148 - A148
  • [10] PHARMACOSCOPY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
    Le Rhun, Emilie
    Mena, Julien
    Lee, Sohyon
    Festl, Yasmin
    Buck, Alicia
    Voglis, Stefanos
    Zeitlberger, Anna Maria
    Weiss, Tobias
    Serra, Carlo
    Neidert, Marian
    Regli, Luca
    Weller, Michael
    Snijder, Berend
    NEURO-ONCOLOGY, 2024, 26